SCHEMBL31240410

SCHEMBL31240410

CC(C)N(C)Cc1c(F)cc(-c2cc3c(-c4ccc5[nH]nc(N)c5c4)ccnc3[nH]2)cc1F

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 11/20 0.44
▸ CLK2 P49760 10/20 0.44
▸ CLK3 P49761 9/20 0.44
▸ CHUK O15111 2/20 0.41
▸ INSR P06213 2/20 0.41
▸ MAPK8 P45983 2/20 0.41
▸ CAMKK2 Q96RR4 2/20 0.41
▸ ALOX5AP P20292 1/20 0.40
▸ FEN1 P39748 1/20 0.40
▸ AURKA O14965 1/20 0.39
▸ AURKB Q96GD4 1/20 0.39
▸ INCENP Q9NQS7 1/20 0.39
▸ TPX2 Q9ULW0 1/20 0.39
▸ WNT1 P04628 2/20 0.38
▸ CCNT1 O60563 2/20 0.38
▸ CDK9 P50750 2/20 0.38
▸ TLR8 Q9NR97 1/20 0.37
▸ TLR7 Q9NYK1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31240369 0.91 CHUK (0.47) DYRK1ACLK2CLK3CHUKINSR
SCHEMBL31240583 0.84 CLK2 (0.42) DYRK1ACLK2CLK3CHUKINSR
SCHEMBL26685953 0.83 TLR8 (0.41) DYRK1ACLK2CLK3CHUKAURKB
SCHEMBL31240632 0.83 CLK2 (0.41) DYRK1ACLK2CLK3CHUKINSR
SCHEMBL31240498 0.80 CLK2 (0.52) DYRK1ACLK2CLK3WNT1CCNT1
SCHEMBL31240596 0.80 CLK2 (0.48) DYRK1ACLK2CLK3CHUKINSR
SCHEMBL31240700 0.80 CLK2 (0.58) DYRK1ACLK2CLK3
SCHEMBL31240412 0.79 CLK2 (0.51) DYRK1ACLK2CLK3WNT1
SCHEMBL31240258 0.79 DYRK1A (0.44) DYRK1ACLK2CLK3WNT1
SCHEMBL31240586 0.77 CLK2 (0.52) DYRK1ACLK2CLK3WNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP disclosed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO disclosed
Send feedback